Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Digi
    Junior Member
    • Oct 2007
    • 4

    #1

    Affy Sues Illumina in genome-analysis and array technologies

    Affy recently(Oct 26th, 2007) filed additional patent-infringement lawsuit against Illumina.

    See detail news:
    http://www.genomeweb.com/issues/news/142940-1.html

    Due to significance of the decision, we will discuss about patent claims in near future.
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Great topic to start off this forum, thanks B.

    This Forbes article has a bit more info, particularly the patent filings that Affy is claiming are infringed upon:

    In the new suits Affymetrix accuses Illumina of infringing US Patents No. 5,902,723, No. 6,403,320, No. 6,420,169, No. 6,576,424, and No. 7,056,666; and in the UK and Germany under European Patents No. 0834575, No. 0853679, and No. 0799897.
    Google patent links here:
    • 5,902,723: Analysis of surface immobilized polymers utilizing microfluorescence detection
    • 6,403,320: Support bound probes and methods of analysis using the same
    • 6,420,169: Apparatus for forming polynucleotides or polypeptides
    • 6,576,424: Arrays and methods for detecting nucleic acids
    • 7,056,666: Analysis of surface immobilized polymers utilizing microfluorescence detection


    There is a fair amount of information on Affy's investor webpage

    Comment

    • apfejes
      Senior Member
      • Feb 2008
      • 236

      #3
      Just to complete this discussion, it seems that the dispute was settled.

      Press Release on Affymetrix's web page

      and see also the thread started by ECO:
      The more you know, the more you know you don't know. —Aristotle

      Comment

      • seqinquire
        Junior Member
        • Jul 2013
        • 4

        #4
        I am very interested in the impact of this patent dispute on users. Any comments will be appreciated!

        Comment

        • SNPsaurus
          Registered Vendor
          • May 2013
          • 525

          #5
          I haven't felt any impact. What are some ways there may be an impact?
          Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

          Comment

          • seqinquire
            Junior Member
            • Jul 2013
            • 4

            #6
            Maybe the effect was that some potential user/buyers were discouraged from buying Illumina because of the pending lawsuit during the litigation.

            For example, Affy was seeking an injunction against any sale of Illumina products. So if the injunction was approved by the court, the choice of Illumina may have seemed risky to buyers/users during the litigation.

            Comment

            • SNPsaurus
              Registered Vendor
              • May 2013
              • 525

              #7
              We bought a GAII in early 2008, so were considering a purchase during this timeframe. I don't think it weighed heavily in the discussion for us. It seems that these large companies sue each other all the time, but nearly always find a way to continue doing business after some payment is made.
              Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

              Comment

              • seqinquire
                Junior Member
                • Jul 2013
                • 4

                #8
                Thanks SNPsaurus for comment. So the many patent lawsuit are the games among manufacturers, and users in this market do not get affected. Very helpful!

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                  by SEQadmin2



                  Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                  Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                  ...
                  10-14-2026, 09:55 AM
                • SEQadmin2
                  New Genomics Technologies Take Aim at Long-Standing Limits
                  by SEQadmin2


                  Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                  We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                  ...
                  09-28-2026, 10:25 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 10-15-2026, 10:52 AM
                0 responses
                14 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-14-2026, 05:39 AM
                0 responses
                21 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-13-2026, 09:56 AM
                0 responses
                19 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-09-2026, 11:14 AM
                0 responses
                27 views
                0 reactions
                Last Post SEQadmin2  
                Working...